| Genetic differences in lethality of newborn mice treated in utero with coplanar versus non-coplanar hexabromobiphenyl. | |
MedLine Citation:
|
PMID: 16291824 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Polybrominated biphenyl (PBB) exposure in humans is known to cause immunotoxicity and disorders related to the central nervous system. Coplanar PBBs bind to the aryl hydrocarbon receptor (AHR) in vertebrates. We compared the coplanar PBB, 3,3',4,4',5,5'-hexabromobiphenyl (cHBB), with its stereoisomer, the non-coplanar PBB, 2,2',4,4'6,6'-hexabromobiphenyl (ncHBB), using C57BL/6J (B6) inbred mice (having the high-affinity AHR) and congenic B6.D2-Ahr d mice (having the low-affinity AHR in a >99.8% C57BL/6J genetic background). Pregnant dams were treated i.p. with vehicle alone, cHBB, or ncHBB on gestational day 5 (GD 5). Unexpectedly, neonatal lethality within the first 72 h postpartum was significant in cHBB-treated B6 mice at doses as low as 2.5 mg/kg, whereas no deaths were seen in B6 pups whose mother had received ncHBB 100 mg/kg or in either B6.D2-Ahr d or Ahr(-/-) knockout mice whose mother had received cHBB 100 mg/kg. Histological and gross anatomical analyses of a battery of tissues in the mother or fetus at GD 18, as well as 24 h postpartum, revealed no significant differences, except for decreased thymus and spleen weights in cHBB-treated B6 GD 18 fetuses. Cross-fostering and genetics experiments confirmed the association of neonatal deaths principally with in utero (rather than lactational) exposure to cHBB, and also no paternal effect. For the end points of mouse neonatal lethality and immunotoxicity, cHBB appears to act through the high-affinity AHR receptor. Although dioxin in utero is well known to cause AHR-dependent cleft palate and hydronephrosis, cHBB did not; thus, chronic activation of the AHR appears to be necessary but not sufficient for AHR-mediated teratogenicity. |
Authors:
|
Christine P Curran; Kevin A Miller; Timothy P Dalton; Charles V Vorhees; Marian L Miller; Howard G Shertzer; Daniel W Nebert |
Related Documents
:
|
23232684 - A very rare type of primary hyperparathyroidism with severe hypercalcemia in an infant. 17041514 - Risk of damage to the endolymphatic sac and duct during removal of the posterior meatal... 1925824 - The incidence of retinopathy of prematurity at groote schuur hospital, cape town. 17608544 - Birth prevalence of oral clefting in northern iran. 24599434 - Severe vitamin b12 deficiency with pancytopenia, hepatosplenomegaly and leukoerythrobla... 24582994 - Importance of birth weight as a risk factor for severe retinopathy of prematurity when ... |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural Date: 2005-11-16 |
Journal Detail:
|
Title: Toxicological sciences : an official journal of the Society of Toxicology Volume: 89 ISSN: 1096-6080 ISO Abbreviation: Toxicol. Sci. Publication Date: 2006 Feb |
Date Detail:
|
Created Date: 2006-01-12 Completed Date: 2006-03-10 Revised Date: 2010-09-17 |
Medline Journal Info:
|
Nlm Unique ID: 9805461 Medline TA: Toxicol Sci Country: United States |
Other Details:
|
Languages: eng Pagination: 454-64 Citation Subset: IM |
Affiliation:
|
Department of Environmental Health, University of Cincinnati Medical Center, P.O. Box 670056, Cincinnati OH 45267-0056, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Animals, Newborn Brain / drug effects, ultrastructure Cytochrome P-450 CYP1A1 / biosynthesis Environmental Pollutants / pharmacokinetics, toxicity* Enzyme Induction Female Gestational Age Injections, Intraperitoneal Liver / drug effects, enzymology, ultrastructure Male Mice Mice, Inbred C57BL Mice, Knockout Polybrominated Biphenyls / pharmacokinetics, toxicity* Pregnancy Prenatal Exposure Delayed Effects / chemically induced, genetics* Receptors, Aryl Hydrocarbon / genetics* Stereoisomerism Structure-Activity Relationship |
| Grant Support | |
ID/Acronym/Agency:
|
P30 ES06096/ES/NIEHS NIH HHS; R01 ES08147/ES/NIEHS NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/2,2',4,4',6,6'-hexabromobiphenyl; 0/Environmental Pollutants; 0/Polybrominated Biphenyls; 0/Receptors, Aryl Hydrocarbon; 60044-26-0/3,3',4,4',5,5'-hexabromobiphenyl; EC 1.14.14.1/Cytochrome P-450 CYP1A1 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Estradiol-17beta stimulates proliferation of mouse embryonic stem cells: involvement of MAPKs and CD...
Next Document: Dietary copper enhances the peripheral myelinopathy produced by oral pyrrolidine dithiocarbamate.